AAPL347.96+3.97 (+1.15%) ▲|ABBV284.63-0.17 (-0.06%) ▼|ABT102.52+2.01 (+2.00%) ▲|ACN258.74+18.48 (+7.69%) ▲|ADBE270.55+15.49 (+6.07%) ▲|AMAT375.58-33.36 (-8.16%) ▼|AMD507.93-44.79 (-8.10%) ▼|AMGN447.28+8.94 (+2.04%) ▲|AMT181.60+3.96 (+2.23%) ▲|AMZN250.38-11.99 (-4.57%) ▼|AVGO323.24-14.56 (-4.31%) ▼|AXP325.07+1.46 (+0.45%) ▲|BA187.53-4.75 (-2.47%) ▼|BAC51.10+0.32 (+0.63%) ▲|BKNG161.10+2.72 (+1.72%) ▲|BLK1,137.54-12.06 (-1.05%) ▼|BMY63.01+1.89 (+3.09%) ▲|BNY145.32-0.53 (-0.36%) ▼|BRK-B547.00+8.01 (+1.49%) ▲|C122.56-1.29 (-1.04%) ▼|CAT703.84-36.38 (-4.91%) ▼|CL97.40+4.00 (+4.28%) ▲|CMCSA22.84+0.76 (+3.44%) ▲|COF203.44-3.22 (-1.56%) ▼|COP145.64-0.03 (-0.02%) ▼|COST1,018.21+19.90 (+1.99%) ▲|CRM250.24+8.46 (+3.50%) ▲|CSCO104.89-2.37 (-2.21%) ▼|CVS94.49+1.71 (+1.84%) ▲|CVX226.65-0.13 (-0.06%) ▼|DE643.60+7.06 (+1.11%) ▲|DHR229.88-3.98 (-1.70%) ▼|DIS113.14+1.31 (+1.17%) ▲|DUK125.42+4.75 (+3.94%) ▲|EMR160.26-2.85 (-1.75%) ▼|FDX303.99+5.76 (+1.93%) ▲|GD350.76+6.05 (+1.75%) ▲|GE293.51-2.37 (-0.80%) ▼|GEV827.38-98.55 (-10.64%) ▼|GILD157.19+3.62 (+2.36%) ▲|GM77.22+1.11 (+1.46%) ▲|GOOG320.76-10.19 (-3.08%) ▼|GOOGL324.22-10.54 (-3.15%) ▼|GS891.27-13.45 (-1.49%) ▼|HD327.66+13.52 (+4.30%) ▲|HON218.31+3.58 (+1.67%) ▲|IBM252.19+0.73 (+0.29%) ▲|INTC85.49-7.47 (-8.04%) ▼|INTU354.90+19.29 (+5.75%) ▲|ISRG443.85+15.73 (+3.67%) ▲|JNJ267.68+9.90 (+3.84%) ▲|JPM336.51+1.32 (+0.39%) ▲|KO95.34+2.66 (+2.87%) ▲|LIN510.36+9.79 (+1.96%) ▲|LLY1,306.74+35.99 (+2.83%) ▲|LMT590.20+38.69 (+7.01%) ▲|LOW204.39+7.83 (+3.98%) ▲|LRCX230.15-30.66 (-11.76%) ▼|MA632.81+10.19 (+1.64%) ▲|MCD252.55+6.30 (+2.56%) ▲|MDLZ65.19+2.45 (+3.91%) ▲|MDT96.58+3.55 (+3.82%) ▲|META648.85-48.67 (-6.98%) ▼|MMM175.54+0.80 (+0.46%) ▲|MO76.07+2.24 (+3.03%) ▲|MRK147.25-2.63 (-1.75%) ▼|MS183.94-3.08 (-1.64%) ▼|MSFT521.08-11.87 (-2.23%) ▼|MU856.49-57.18 (-6.26%) ▼|NEE81.91+3.63 (+4.64%) ▲|NFLX67.05+2.01 (+3.09%) ▲|NKE38.31+0.78 (+2.08%) ▲|NOW157.00+3.88 (+2.53%) ▲|NVDA212.21-9.76 (-4.40%) ▼|ORCL125.52-3.62 (-2.80%) ▼|PEP138.83+4.13 (+3.07%) ▲|PFE30.41+0.56 (+1.88%) ▲|PG165.60+8.76 (+5.59%) ▲|PLTR196.19-5.53 (-2.74%) ▼|PM201.76+4.30 (+2.18%) ▲|QCOM172.83-5.13 (-2.88%) ▼|RTX194.71+3.11 (+1.62%) ▲|SBUX101.91+2.83 (+2.86%) ▲|SCHW91.44-0.20 (-0.22%) ▼|SO93.82+3.43 (+3.79%) ▲|SPG212.04+6.49 (+3.16%) ▲|T22.74+0.83 (+3.79%) ▲|TMO676.55-17.47 (-2.52%) ▼|TMUS158.79+5.04 (+3.28%) ▲|TSLA374.58-11.89 (-3.08%) ▼|TXN279.50-5.15 (-1.81%) ▼|UBER69.07+1.45 (+2.14%) ▲|UNH424.98+7.98 (+1.91%) ▲|UNP298.09+10.22 (+3.55%) ▲|UPS101.52+1.95 (+1.96%) ▲|USB60.02+0.97 (+1.64%) ▲|V414.34+6.49 (+1.59%) ▲|VZ45.20+1.64 (+3.76%) ▲|WFC83.01+0.59 (+0.72%) ▲|WMT121.12+3.32 (+2.82%) ▲|XOM178.23+0.14 (+0.08%) ▲|AAPL347.96+3.97 (+1.15%) ▲|ABBV284.63-0.17 (-0.06%) ▼|ABT102.52+2.01 (+2.00%) ▲|ACN258.74+18.48 (+7.69%) ▲|ADBE270.55+15.49 (+6.07%) ▲|AMAT375.58-33.36 (-8.16%) ▼|AMD507.93-44.79 (-8.10%) ▼|AMGN447.28+8.94 (+2.04%) ▲|AMT181.60+3.96 (+2.23%) ▲|AMZN250.38-11.99 (-4.57%) ▼|AVGO323.24-14.56 (-4.31%) ▼|AXP325.07+1.46 (+0.45%) ▲|BA187.53-4.75 (-2.47%) ▼|BAC51.10+0.32 (+0.63%) ▲|BKNG161.10+2.72 (+1.72%) ▲|BLK1,137.54-12.06 (-1.05%) ▼|BMY63.01+1.89 (+3.09%) ▲|BNY145.32-0.53 (-0.36%) ▼|BRK-B547.00+8.01 (+1.49%) ▲|C122.56-1.29 (-1.04%) ▼|CAT703.84-36.38 (-4.91%) ▼|CL97.40+4.00 (+4.28%) ▲|CMCSA22.84+0.76 (+3.44%) ▲|COF203.44-3.22 (-1.56%) ▼|COP145.64-0.03 (-0.02%) ▼|COST1,018.21+19.90 (+1.99%) ▲|CRM250.24+8.46 (+3.50%) ▲|CSCO104.89-2.37 (-2.21%) ▼|CVS94.49+1.71 (+1.84%) ▲|CVX226.65-0.13 (-0.06%) ▼|DE643.60+7.06 (+1.11%) ▲|DHR229.88-3.98 (-1.70%) ▼|DIS113.14+1.31 (+1.17%) ▲|DUK125.42+4.75 (+3.94%) ▲|EMR160.26-2.85 (-1.75%) ▼|FDX303.99+5.76 (+1.93%) ▲|GD350.76+6.05 (+1.75%) ▲|GE293.51-2.37 (-0.80%) ▼|GEV827.38-98.55 (-10.64%) ▼|GILD157.19+3.62 (+2.36%) ▲|GM77.22+1.11 (+1.46%) ▲|GOOG320.76-10.19 (-3.08%) ▼|GOOGL324.22-10.54 (-3.15%) ▼|GS891.27-13.45 (-1.49%) ▼|HD327.66+13.52 (+4.30%) ▲|HON218.31+3.58 (+1.67%) ▲|IBM252.19+0.73 (+0.29%) ▲|INTC85.49-7.47 (-8.04%) ▼|INTU354.90+19.29 (+5.75%) ▲|ISRG443.85+15.73 (+3.67%) ▲|JNJ267.68+9.90 (+3.84%) ▲|JPM336.51+1.32 (+0.39%) ▲|KO95.34+2.66 (+2.87%) ▲|LIN510.36+9.79 (+1.96%) ▲|LLY1,306.74+35.99 (+2.83%) ▲|LMT590.20+38.69 (+7.01%) ▲|LOW204.39+7.83 (+3.98%) ▲|LRCX230.15-30.66 (-11.76%) ▼|MA632.81+10.19 (+1.64%) ▲|MCD252.55+6.30 (+2.56%) ▲|MDLZ65.19+2.45 (+3.91%) ▲|MDT96.58+3.55 (+3.82%) ▲|META648.85-48.67 (-6.98%) ▼|MMM175.54+0.80 (+0.46%) ▲|MO76.07+2.24 (+3.03%) ▲|MRK147.25-2.63 (-1.75%) ▼|MS183.94-3.08 (-1.64%) ▼|MSFT521.08-11.87 (-2.23%) ▼|MU856.49-57.18 (-6.26%) ▼|NEE81.91+3.63 (+4.64%) ▲|NFLX67.05+2.01 (+3.09%) ▲|NKE38.31+0.78 (+2.08%) ▲|NOW157.00+3.88 (+2.53%) ▲|NVDA212.21-9.76 (-4.40%) ▼|ORCL125.52-3.62 (-2.80%) ▼|PEP138.83+4.13 (+3.07%) ▲|PFE30.41+0.56 (+1.88%) ▲|PG165.60+8.76 (+5.59%) ▲|PLTR196.19-5.53 (-2.74%) ▼|PM201.76+4.30 (+2.18%) ▲|QCOM172.83-5.13 (-2.88%) ▼|RTX194.71+3.11 (+1.62%) ▲|SBUX101.91+2.83 (+2.86%) ▲|SCHW91.44-0.20 (-0.22%) ▼|SO93.82+3.43 (+3.79%) ▲|SPG212.04+6.49 (+3.16%) ▲|T22.74+0.83 (+3.79%) ▲|TMO676.55-17.47 (-2.52%) ▼|TMUS158.79+5.04 (+3.28%) ▲|TSLA374.58-11.89 (-3.08%) ▼|TXN279.50-5.15 (-1.81%) ▼|UBER69.07+1.45 (+2.14%) ▲|UNH424.98+7.98 (+1.91%) ▲|UNP298.09+10.22 (+3.55%) ▲|UPS101.52+1.95 (+1.96%) ▲|USB60.02+0.97 (+1.64%) ▲|V414.34+6.49 (+1.59%) ▲|VZ45.20+1.64 (+3.76%) ▲|WFC83.01+0.59 (+0.72%) ▲|WMT121.12+3.32 (+2.82%) ▲|XOM178.23+0.14 (+0.08%) ▲|
19.5 C
New York
Thursday, October 22, 2026

Tag: science

newsFORsourcecompanycontentinformation1releasesmarket

Trial Evaluating Blood Test for 10 Cancers Reaches Major Milestone

SOUTHAMPTON, England, July 30, 2025 /PRNewswire/ -- MODERNISED (NIHR207538), a multi-site UK clinical study has passed a key milestone: over 450 participants have joined the...

Trial Evaluating Blood Test for 10 Cancers Reaches Major Milestone

SOUTHAMPTON, England, July 30, 2025 /PRNewswire/ -- MODERNISED (NIHR207538), a multi-site UK clinical study has passed a key milestone: over 450 participants have joined the...

Tarsus to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025

IRVINE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on Wednesday, August 6, 2025, to report its second quarter 2025 financial results and provide a corporate update.

Azenta to Participate in 10th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference

BURLINGTON, Mass., July 30, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 10th Annual Needham Virtual...

ORANGETHEORY FITNESS CANADA PARTNERS WITH OLÉ COCKTAIL CO. TO LAUNCH NO SHOWER HAPPY HOUR — A NATIONWIDE CELEBRATION OF MOVEMENT + COMMUNITY

Celebrating fitness, balance, and connection with post-sweat sips in 100+ studios across Canada EDMONTON, AB, July 30, 2025 /CNW/ - This August, Orangetheory Fitness Canada...

UMD Smith Study Produces Transformer-based AI Approach to Predicting Customer Behavior

COLLEGE PARK, Md., July 30, 2025 /PRNewswire/ -- Marketing researchers at the University of Maryland's Robert H. Smith School of Business have produced an artificial...

Eviva Partners Launches New Think Tank, Exposes Attack on Aluminum-Containing Vaccines

NEW YORK, July 30, 2025 /PRNewswire/ -- Eviva Partners, a nonprofit organization dedicated to strengthening public understanding of medical evidence, is proud to announce...

ARCHIMED Acquires a Majority Stake in Arkstone, Forging a Powerful Partnership to Accelerate Global Healthcare Innovation And Dominate the Emerging AI-Driven Clinical Decision Support...

Arkstone, an innovative biotechnology company democratizing infectious disease expertise and fighting antimicrobial resistance, has been acquired by global healthcare private equity firm ARCHIMED, which...

Seasats Autonomous Surface Vessel Crosses The Pacific, Completes 7,500+ Mile Mission

SAN DIEGO, July 30, 2025 /PRNewswire/ -- Seasats, a leader in autonomous maritime systems, announced today that one of the company's autonomous surface vessels...

Final results

FORESIGHT VENTURES VCT PLC
LEI: 213800R88MRC4Y3OIW86
29 July 2025

Two-Year Real-World Study of LEQEMBI® in the United States Presented at Alzheimer’s Association International Conference (AAIC) 2025

TOKYO and CAMBRIDGE, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the two-year real-world study in the U.S of lecanemab (generic name, product name: LEQEBMI®), an anti-Aβ protofibril* antibody, was presented at the Alzheimer's Association International Conference (AAIC) 2025, held in Toronto, Canada and virtually. Only lecanemab fights AD in two ways – targeting both amyloid plaque and protofibrils*, which can impact tau downstream.

LearnLux Celebrates Five Years of Financial Wellbeing Partnership with Messer Construction Co.

BOSTON, July 30, 2025 /PRNewswire/ -- LearnLux, the leading workplace financial wellbeing provider, is proud to celebrate the fifth anniversary and continued success of...

Anime Market to Grow at a CAGR of 9.6% from 2025 to 2032 | SkyQuest Technology Consulting

The Anime market is anticipated to increase due to rapidly expanding international fanbase, especially among Gen Z and millennials. Increased accessibility through streaming platforms...

Anime Market to Grow at a CAGR of 9.6% from 2025 to 2032 | SkyQuest Technology Consulting

The Anime market is anticipated to increase due to rapidly expanding international fanbase, especially among Gen Z and millennials. Increased accessibility through streaming platforms...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsScience

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers